Delivery Order SPE2DB25D9321-SPE2DB25FQWPH
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,353.77 by the Defense Logistics Agency on August 22, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count). This firm fixed-price delivery order is scheduled for completion by September 15, 2025, with performance taking place at the vendor's Park Ridge location. The award was made without a set-aside designation, reflecting...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,006.95 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the supply of LENVIMA 20MG DAILY 60S, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which covers a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for LENVIMA 8 mg daily dose tablets (60-count supply) with a ceiling value of $11,353.77. This firm fixed-price delivery order, awarded on August 28, 2025, with an ultimate completion date of September 19, 2025, represents a procurement of a specialized oncology medication. The contract carries no set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,006.95 firm fixed-price delivery order is for the supply of Lenvima 10 mg daily dose 30s, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm...
- The Defense Logistics Agency Troop Support Medical has awarded DMS Pharmaceutical Group Inc. a firm fixed price delivery order for $10,662.16 to supply 60 units of Lenvima 20 mg daily dose tablets. The place of performance is Park Ridge, Illinois and the completion date is December 13, 2023. No set-aside designation was used for this award. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler that holds an indefinite delivery contract with the Defense Logistics...
- This federal contract award, valued at $11,006.95, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the pharmaceutical product Lenvima 10 mg daily dose 30s, with a completion date of November 13, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Lenvima 4 mg capsules. The contract has a potential value of $31,986.48 and a completion date of March 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a range of branded and generic prescription drugs and medical supplies to U.S. government...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $11,006.95 for the pharmaceutical product Lenvima 20mg daily, 60 capsules. The award was made by the Defense Logistics Agency (DLA), a defense agency, under an Indefinite Delivery Contract (IDC) valued at $499,999,999 that enables the DLA to issue delivery orders for a range of pharmaceutical products to support the medical supply needs of military health facilities...
- The U.S. Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. for LENVIMA 20 mg daily dose (60-count supply) valued at $11,353.77 on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order was awarded without set-aside designation to the Park Ridge, Illinois-based woman-owned small business pharmaceutical wholesaler. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- This federal contract award is a firm fixed-price delivery order valued at $11,006.95 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the delivery of Lenvima 20 mg daily dose 60-count prescription drug products to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract...
- SPE2DB25D9321Indefinite Delivery Contract
- SPE2DB25D9321-SPE2DB25FQWPHDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,353.77 by the Defense Logistics Agency on August 28, 2025, for the supply of Lenvima 14 mg daily dose tablets in quantities of 60 units. The contract carries an ultimate completion date of September 19, 2025, and does not utilize a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 vehicle valid through November 2026 that authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products supporting Department of Defense medical facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in Defense Logistics Agency procurement markets. The company's robust contract portfolio demonstrates consistent success in delivering branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems. As a SAM.gov-registered entity since 2001, the company provides direct pharmaceutical distribution and pharmacy services across the extensive range of products authorized under its master indefinite delivery contract, positioning it as a preferred vendor for Department of Defense healthcare supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 8/28/25 |